Tuning silence: Conditional systems for RNA interference

Nature Methods

Volumn 3, Issue 9, 2006, Pages 682-688

  Wiznerowicz, Maciej ^a   Szulc, Jolanta ^a   Trono, Didier ^a  

^a EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CRE RECOMBINASE; DNA DIRECTED RNA POLYMERASE III; DNA METHYLTRANSFERASE; DOXYCYCLINE; LENTIVIRUS VECTOR; MICRORNA; PROTEIN P53; REPRESSOR PROTEIN; RETROVIRUS VECTOR; RNA POLYMERASE II; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR CDX2; TUMOR SUPPRESSOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DOWN REGULATION; EMBRYONIC STEM CELL; ENZYME ACTIVATION; ENZYME INACTIVATION; EPIGENETICS; GENE EXPRESSION REGULATION; GENE LIBRARY; GENE REPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RNA INTERFERENCE; RNA TRANSCRIPTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR; TUMOR REGRESSION; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM;

GENETIC VECTORS; HUMANS; LENTIVIRUS; RNA INTERFERENCE; RNA POLYMERASE III; RNA, SMALL INTERFERING;

EID: 33747778686     PISSN: 15487091     EISSN: 15491676     Source Type: Journal    
DOI: 10.1038/nmeth914     Document Type: Article

References (41)

1. Elbashir, S.M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498 (2001).
2. Hannon, G.J. & Rossi, J.J. Unlocking the potential of the human genome with RNA interference. Nature 431, 371-378 (2004).
3. Brummelkamp, T.R., Bernards, R. & Agami, R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2, 243-247 (2002).
4. Dorsett, Y. & Tuschl, T. siRNAs: Applications in functional genomics and potential as therapeutics. Nat. Rev. Drug Discov. 3, 318-329 (2004).
5. Zeng, Y., Cai, X. & Cullen, B.R. Use of RNA polymerase II to transcribe artificial microRNAs. Methods Enzymol. 392, 371-380 (2005).
6. van de Wetering, M. et al. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep. 4, 609-615 (2003).
7. Hoeflich, K.P. et al. Oncogenic BRAF is required for tumor growth and maintenance in melanoma models. Cancer Res. 66, 999-1006 (2006).
8. Ohkawa, J. & Taira, K. Control of the functional activity of an antisense RNA by a tetracycline-responsive derivative of the human U6 snRNA promoter. Hum. Gene Ther. 11, 577-585 (2000).
9. Chen, Y., Stamatoyannopoulos, G. & Song, C.Z. Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res. 63, 4801-4804 (2003).
10. Matsukura, S., Jones, P.A. & Takai, D. Establishment of conditional vectors for hairpin siRNA knockdowns. Nucleic Acids Res. 31, e77 (2003).
11. Berns, K. et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428, 431-437 (2004).
12. Ngo, V.N. et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature 441, 106-110 (2006).
13. Gupta, S., Schoer, R.A., Egan, J.E., Hannon, G.J. & Mittal, V. Inducible, reversible, and stable RNA interference in mammalian cells. Proc. Natl. Acad. Sci. USA 101, 1927-1932 (2004).
14. Amar, L., Desclaux, M., Faucon-Biguet, N., Mallet, J. & Vogel, R. Control of small inhibitory RNA levels and RNA interference by doxycycline induced activation of a minimal RNA polymerase III promoter. Nucleic Acids Res. 34, e37 (2006).
15. Wiznerowicz, M. & Trono, D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J. Virol. 77, 8957-8961 (2003).
16. Szulc, J., Wiznerowicz, M., Sauvain, M.O., Trono, D. & Aebischer, P. A versatile tool for conditional gene expression and knockdown. Nat. Methods 3, 109-116 (2006).
17. Arrighi, J.F. et al. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells. J. Virol. 78, 10848-10855 (2004).
18. Miyake, K. et al. Development of cellular models for ribosomal protein S19 (RPS19)-deficient diamond-blackfan anemia using inducible expression of siRNA against RPS19. Mol. Ther. 11, 627-637 (2005).
19. Toniatti, C., Bujard, H., Cortese, R. & Ciliberto, G. Gene therapy progress and prospects: Transcription regulatory systems. Gene Ther. 11, 649-657 (2004).
20. Zeng, Y. & Cullen, B.R. Efficient processing of primary microRNA hairpins by Drosha requires flanking nonstructured RNA sequences. J. Biol. Chem. 280, 27595-27603 (2005).
21. Stegmeier, F., Hu, G., Rickles, R.J., Hannon, G.J. & Elledge, S.J. A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc. Natl. Acad. Sci. USA 102, 13212-13217 (2005).
22. Dickins, R.A. et al. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat. Genet. 37, 1289-1295 (2005).
23. Garcia-Otin, A.L. & Guillou, F. Mammalian genome targeting using site-specific recombinases. Front. Biosci. 11, 1108-1136 (2006).
24. Tiscornia, G., Tergaonkar, V., Galimi, F. & Verma, I.M. CRE recombinase-inducible RNA interference mediated by lentiviral vectors. Proc. Natl. Acad. Sci. USA 101, 7347-7351 (2004).
25. Ventura, A. et al. Cre-lox-regulated conditional RNA interference from transgenes. Proc. Natl. Acad. Sci. USA 101, 10380-10385 (2004).
26. Meissner, A. & Jaenisch, R. Generation of nuclear transfer-derived pluripotent ES cells from cloned Cdx2-deficient blastocysts. Nature 439, 212-215 (2006).
27. Chang, H.S., Lin, C.H., Chen, Y.C. & Yu, W.C. Using siRNA technique to generate transgenic animals with spatiotemporal and conditional gene knockdown. Am. J. Pathol. 165, 1535-1541 (2004).
28. Li, M.J. & Rossi, J.J. Lentiviral vector delivery of recombinant small interfering RNA expression cassettes. Methods Enzymol. 392, 218-226 (2005).
29. Tiscornia, G., Singer, O., Ikawa, M. & Verma, I.M. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl. Acad. Sci. USA 100, 1844-1848 (2003).
30. Zufferey, R., Nagy, D., Mandel, R.J., Naldini, L. & Trono, D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15, 871-875 (1997).
31. Naldini, L. et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267 (1996).
32. Lois, C., Hong, E.J., Pease, S., Brown, E.J. & Baltimore, D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295, 868-872 (2002).
33. Moffat, J. et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124, 1283-1298 (2006).
34. Kuninger, D. et al. Gene disruption by regulated short interfering RNA expression, using a two-adenovirus system. Hum. Gene Ther. 15, 1287-1292 (2004).
35. Li, L. et al. Evaluating hypoxia-inducible factor-1α as a cancer therapeutic target via inducible RNA interference in vivo. Cancer Res. 65, 7249-7258 (2005).
36. Matthess, Y. et al. Conditional inhibition of cancer cell proliferation by tetracycline-responsive, H1 promoter-driven silencing of PLK1. Oncogene 24, 2973-2980 (2005).
37. Ito, T. et al. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo. Clin. Cancer Res. 12, 1308-1316 (2006).
38. Lin, X. et al. Development of a tightly regulated U6 promoter for shRNA expression. FEBS Lett. 577, 376-380 (2004).
39. Leenders, F. et al. PKN3 is required for malignant prostate cell growth downstream of activated PI 3-kinase. EMBO J. 23, 3303-3313 (2004).
40. Brown, S.A. et al. PERIOD1-associated proteins modulate the negative limb of the mammalian circadian oscillator. Science 308, 693-696 (2005).
41. Yu, J. & McMahon, A.P. Reproducible and inducible knockdown of gene expression in mice. Genesis 44, 252-261 (2006).